Mary Frances McMullin, MD, FRCP, FRCPath - Managing Myelofibrosis: Can We Do More to Address Cytopenias, Reduce Transfusion Burden, and Improve Quality of Life?

Visit https://www.peervoice.com/YTE860 to view the entire programme with slides. After completing “Mary Frances McMullin, MD, FRCP, FRCPath - Managing Myelofibrosis: Can We Do More to Address Cytopenias, Reduce Transfusion Burden, and Improve Quality of Life?”, participants will be able to: Identify therapeutic limitations associated with current treatment options for patients with cytopenic myelofibrosis; Assess the latest clinical evidence for emerging first- and second-line therapies for patients with cytopenic myelofibrosis; and Formulate treatment plans for patients with myelofibrosis that consider patient-, disease-, and drug-related factors.